ArticlePharmaceuticals (Basel, Switzerland)2025

Preclinical Efficacy and Safety of an Oncolytic Adenovirus KD01 for the Treatment of Bladder Cancer.

Jin Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.